加载页面时好像出了点问题.
我们的团队已经注意到了，但如果问题仍然存在，请使用电子邮件支持小工具联系我们。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | No | No |
| Is equity multiplier increasing? | Yes | No |
| Competitors Used |
|---|
| Yield10 Bioscience, Inc. |
| Dyadic International, Inc. |
| Onconetix, Inc. |
| Geron Corporation |
| Trevena, Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| YTEN.Q | DYAI | ONCO | GERN | TRVN | ARTV | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 450% | -114% | -234% | -66% | 344% | -30% | ||
| Fiscal Year - 1 | -133% | -66% | NA | -112% | -134% | 51% | ||
| Fiscal Year - 2 | -86% | -56% | NA | -137% | -61% | 130% | ||
| Fiscal Year - 3 | -375% | -29% | NA | -69% | -44% | NA | ||
| Fiscal Year - 4 | -1606% | -21% | NA | -44% | -69% | NA | ||
| Fiscal Year - 5 | -100% | -12% | NA | -44% | -81% | NA | ||
| Average | -308% | -50% | -234% | -79% | -7% | 50% | ||
| Median | -116% | -42% | -234% | -67% | -65% | 51% | ||
| Benchmarks | Ticker | |||||||
| Yield10 Bioscience, Inc. | OTCPK:YTEN.Q | |||||||
| Dyadic International, Inc. | NasdaqCM:DYAI | |||||||
| Onconetix, Inc. | NasdaqCM:ONCO | |||||||
| Geron Corporation | NasdaqGS:GERN | |||||||
| Trevena, Inc. | OTCPK:TRVN | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | YTEN.Q | DYAI | ONCO | GERN | TRVN | ARTV | ||
| Latest Fiscal Year | Dec-23 | Dec-23 | Dec-23 | Dec-24 | Dec-23 | Dec-23 | ||
| LTM Period | Jun-24 | Sep-24 | Sep-24 | Dec-24 | Sep-24 | Sep-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 1 | 3 | 2 | 77 | 1 | 3 | ||
| Fiscal Year | 0 | 3 | 0 | 77 | 3 | 33 | ||
| Fiscal Year - 1 | 0 | 3 | NA | 0 | (0) | 5 | ||
| Fiscal Year - 2 | 1 | 2 | NA | 1 | 1 | 2 | ||
| Fiscal Year - 3 | 1 | 2 | NA | 1 | 3 | NA | ||
| Fiscal Year - 4 | 1 | 2 | NA | 0 | 0 | NA | ||
| Fiscal Year - 5 | 1 | 1 | NA | 0 | 6 | NA | ||
| Net Income | ||||||||
| Latest Twelve Months | (13) | (6) | (52) | (175) | (34) | (61) | ||
| Fiscal Year | (14) | (7) | (37) | (175) | (40) | (29) | ||
| Fiscal Year - 1 | (14) | (10) | (14) | (184) | (54) | (59) | ||
| Fiscal Year - 2 | (11) | (13) | (4) | (142) | (52) | (72) | ||
| Fiscal Year - 3 | (10) | (9) | (2) | (116) | (29) | (18) | ||
| Fiscal Year - 4 | (13) | (8) | (1) | (76) | (25) | (4) | ||
| Fiscal Year - 5 | (9) | (6) | NA | (69) | (31) | NA | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 6 | 9 | 28 | 394 | 45 | NA | ||
| Latest Fiscal Quarter | 3 | 11 | 62 | 594 | 19 | 226 | ||
| Fiscal Year | 4 | 8 | 88 | 594 | 41 | 105 | ||
| Fiscal Year - 1 | 8 | 14 | 26 | 394 | 49 | 133 | ||
| Fiscal Year - 2 | 20 | 21 | 3 | 191 | 80 | 170 | ||
| Fiscal Year - 3 | 15 | 30 | 5 | 226 | 128 | 29 | ||
| Fiscal Year - 4 | 17 | 37 | 6 | 271 | 47 | 5 | ||
| Fiscal Year - 5 | 13 | 43 | NA | 166 | 67 | NA | ||
| Fiscal Year - 6 | 17 | 51 | NA | 185 | 73 | NA | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 1 | 8 | 10 | 248 | 4 | NA | ||
| Latest Fiscal Quarter | (6) | 3 | 34 | 280 | (23) | 201 | ||
| Fiscal Year | (2) | 6 | (6) | 280 | (8) | (162) | ||
| Fiscal Year - 1 | 4 | 11 | 22 | 248 | 16 | (141) | ||
| Fiscal Year - 2 | 16 | 18 | 1 | 80 | 65 | (89) | ||
| Fiscal Year - 3 | 10 | 28 | 5 | 126 | 104 | (22) | ||
| Fiscal Year - 4 | (4) | 36 | 6 | 211 | 30 | (4) | ||
| Fiscal Year - 5 | 6 | 42 | NA | 135 | 42 | NA | ||
| Fiscal Year - 6 | 13 | 50 | NA | 178 | 35 | NA | ||